Azora Therapeutics, Inc. (DE) (AZR)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- 200,000
- Oct 4 · Unusual
- Form 4 sales
- 4
- On record
- Form 144 notices
- 0
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
0
Routine
2
Plan not stated
0
No plan
2
Unusual
Timeline
- Oct 4, 2021Unusual
Johnson Bankole A., Chief Medical Officer, sold 57.4% of their holdings
200,000 shares
- Apr 6, 2021Plan not stated
Johnson Bankole A., Chief Medical Officer, sold 21.5% of their holdings
$375k150,000 shares at $2.50
- Aug 20, 2020Unusual
Johnson Bankole A., Chief Medical Officer, sold 99.7% of their holdings
$424k350,000 shares at $1.21
- Dec 12, 2019Plan not stated
Johnson Bankole A., Chief Medical Officer, sold 17.7% of their holdings
$150k150,000 shares at $1.00
4 of 4
Every transaction
| Traded | Filed | Stock | Name | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | Nov 4, 2026 | AZR | Davidson Matt | President and CEO | ConvertedSeries A Preferred Stock | 626 | 0 | SEC | ||
| Nov 2, 2026 | Nov 4, 2026 | AZR | Davidson Matt | President and CEO | Converted | 626,252 | 104,725 | SEC | ||
| Oct 28, 2026 | Oct 30, 2026 | AZR | Davidson Matt | President and CEO | AwardedSeries A Preferred Stock | 886,128 | 333,830 | SEC | ||
| Oct 28, 2026 | Oct 30, 2026 | AZR | Davidson Matt | President and CEO | Awarded | 232,417 | 294,064 | SEC | ||
| Sep 17, 2026 | Sep 21, 2026 | AZR | Young Wendy B. | Director | AwardedStock Option (Right to Buy) | 25,666 | 25,666 | SEC | ||
| Jul 16, 2026 | Jul 16, 2026 | AZR | Coastlands Capital LP | 10% owner | Bought | 3,233 | $2.69 | $9k | 388,308 | SEC |
| Jul 10, 2026 | Jul 13, 2026 | AZR | Coastlands Capital LP | 10% owner | Bought | 11,753 | $2.78 | $33k | 385,075 | SEC |
| Jun 29, 2026 | Jul 1, 2026 | AZR | Coastlands Capital LP | 10% owner | Bought | 25,000 | $2.60 | $65k | 373,322 | SEC |
| Jun 12, 2026 | Jun 16, 2026 | AZR | Davidson Matt | Chief Development Officer | AwardedStock Option (Right to Buy) | 232,417 | 232,417 | SEC | ||
| Jun 12, 2026 | Jun 16, 2026 | AZR | Davidson Matt | Chief Development Officer | Awarded | 299,414 | 1,923 | SEC | ||
| Jun 12, 2026 | Jun 16, 2026 | AZR | Young Wendy B. | Director | BoughtPre-funded Warrant | 36,378 | $2.75 | $100k | 36,378 | SEC |
| Apr 7, 2026 | Apr 9, 2026 | AZR | Anderson J. Kermit | Director | AwardedStock Option (Right to Buy) | 9,185 | 9,185 | SEC | ||
| Apr 7, 2026 | Apr 9, 2026 | AZR | Goodman Tony | Chief Operating Officer | Awarded | 26,510 | 26,523 | SEC | ||
| Apr 7, 2026 | Apr 9, 2026 | AZR | Shah Vinay | Chief Financial Officer | Awarded | 17,325 | 17,325 | SEC | ||
| Apr 7, 2026 | Apr 9, 2026 | AZR | Schuyler Kevin | Director | Awarded | 9,185 | 9,213 | SEC | ||
| Apr 7, 2026 | Apr 9, 2026 | AZR | Gilliland Robertson H. | Director | Awarded | 9,185 | 9,185 | SEC | ||
| Apr 7, 2026 | Apr 9, 2026 | AZR | Claiborne Cary J | Chief Executive Officer | Awarded | 37,985 | 40,417 | SEC | ||
| May 29, 2025 | Jun 2, 2025 | AZR | Gilliland Robertson H. | Director | AwardedStock Option (Right to Buy) | 28,000 | 28,000 | SEC | ||
| May 29, 2025 | Jun 2, 2025 | AZR | Newman James W. Jr. | Director | AwardedStock Option (Right to Buy) | 28,000 | 28,000 | SEC | ||
| May 29, 2025 | Jun 2, 2025 | AZR | Shah Vinay | Chief Financial Officer | AwardedStock Option (Right to Buy) | 9,000 | 9,000 | SEC | ||
| May 29, 2025 | Jun 2, 2025 | AZR | Schuyler Kevin | Director | AwardedStock Option (Right to Buy) | 28,000 | 28,000 | SEC | ||
| May 29, 2025 | Jun 2, 2025 | AZR | Claiborne Cary J | Chief Executive Officer | AwardedStock Option (Right to Buy) | 138,000 | 138,000 | SEC | ||
| May 29, 2025 | Jun 2, 2025 | AZR | Goodman Tony | Chief Operating Officer | AwardedStock Option (Right to Buy) | 94,000 | 94,000 | SEC | ||
| May 29, 2025 | Jun 2, 2025 | AZR | Anderson J. Kermit | Director | AwardedStock Option (Right to Buy) | 28,000 | 28,000 | SEC | ||
| Dec 5, 2024 | Dec 5, 2024 | AZR | Claiborne Cary J | Chief Executive Officer | AwardedStock Option (Right to Buy) | 350,000 | 350,000 | SEC | ||
| Nov 16, 2024 | Nov 18, 2024 | AZR | Shah Vinay | Chief Financial Officer | AwardedStock Option | 40,000 | 40,000 | SEC | ||
| Mar 25, 2024 | Mar 27, 2024 | AZR | Gilliland Robertson H. | Director | AwardedStock Option (Right to Buy) | 12,000 | 12,000 | SEC | ||
| Mar 25, 2024 | Mar 27, 2024 | AZR | Newman James W. Jr. | Director | AwardedStock Option (Right to Buy) | 12,000 | 12,000 | SEC | ||
| Mar 25, 2024 | Mar 27, 2024 | AZR | Truluck Joseph | Chief Financial Officer | AwardedStock Option (Right to Buy) | 25,000 | 25,000 | SEC | ||
| Mar 25, 2024 | Mar 27, 2024 | AZR | Claiborne Cary J | Chief Executive Officer | AwardedStock Option (Right to Buy) | 60,000 | 60,000 | SEC | ||
| Mar 25, 2024 | Mar 27, 2024 | AZR | Anderson J. Kermit | Director | AwardedStock Option (Right to Buy) | 12,000 | 12,000 | SEC | ||
| Mar 25, 2024 | Mar 27, 2024 | AZR | Schuyler Kevin | Director | AwardedStock Option (Right to Buy) | 12,000 | 12,000 | SEC | ||
| Mar 25, 2024 | Mar 27, 2024 | AZR | Goodman Tony | Chief Operating Officer | AwardedStock Option (Right to Buy) | 42,000 | 42,000 | SEC | ||
| Sep 29, 2023 | Oct 3, 2023 | AZR | Schuyler Kevin | Director | Bought | 700 | $2.74 | $2k | 700 | SEC |
| May 23, 2023 | Jun 2, 2023 | AZR | Johnson Bankole A. | Director | AwardedStock Option | 40,000 | 40,000 | SEC | ||
| May 23, 2023 | May 25, 2023 | AZR | Truluck Joseph | Chief Financial Officer | AwardedStock Option (Right to Buy) | 125,000 | 125,000 | SEC | ||
| May 23, 2023 | May 25, 2023 | AZR | Truluck Joseph | Chief Financial Officer | Awarded | 157,500 | 265,139 | SEC | ||
| May 23, 2023 | May 25, 2023 | AZR | Stilley William B. III | Director | AwardedStock Option (Right to Buy) | 50,000 | 50,000 | SEC | ||
| May 23, 2023 | May 25, 2023 | AZR | Stilley William B. III | Director | Awarded | 240,800 | 1.3M | SEC | ||
| May 23, 2023 | May 25, 2023 | AZR | Schuyler Kevin | Director | AwardedStock Option (Right to Buy) | 50,000 | 50,000 | SEC | ||
| May 23, 2023 | May 25, 2023 | AZR | Newman James W. Jr. | Director | AwardedStock Option (Right to Buy) | 50,000 | 50,000 | SEC | ||
| May 23, 2023 | May 25, 2023 | AZR | Goodman Tony | Director | AwardedStock Option (Right to Buy) | 50,000 | 50,000 | SEC | ||
| May 23, 2023 | May 25, 2023 | AZR | Gilliland Robertson H. | Director | AwardedStock Option (Right to Buy) | 50,000 | 50,000 | SEC | ||
| May 23, 2023 | May 25, 2023 | AZR | Claiborne Cary J | Chief Executive Officer | AwardedStock Option (Right to Buy) | 300,000 | 300,000 | SEC | ||
| May 23, 2023 | May 25, 2023 | AZR | Claiborne Cary J | Chief Executive Officer | Awarded | 420,000 | 1.5M | SEC | ||
| May 23, 2023 | May 25, 2023 | AZR | Anderson J. Kermit | Director | AwardedStock Option (Right to Buy) | 50,000 | 50,000 | SEC | ||
| Dec 30, 2022 | Jan 3, 2023 | AZR | Stilley William B. III | Director | Returned to the company | 166,667 | 1M | SEC | ||
| Sep 20, 2022 | Sep 20, 2022 | AZR | Claiborne Cary J | Chief Executive Officer | Awarded | 100,000 | $0.42 | $42k | 1.1M | SEC |
| Aug 22, 2022 | Aug 23, 2022 | AZR | Stilley William B. III | Director | AwardedStock Options | 100,000 | 100,000 | SEC | ||
| Aug 18, 2022 | Aug 22, 2022 | AZR | Claiborne Cary J | Chief Executive Officer | Awarded | 1M | 1M | SEC |
Page 1
Sales, notices and lockups (4)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 4, 2021 | Oct 6, 2021 | Johnson Bankole A. | AZR | Chief Medical Officer | Form 4 sale | 200,000 | 57.4% | Unusual | SEC | |
| Apr 6, 2021 | Apr 8, 2021 | Johnson Bankole A. | AZR | Chief Medical Officer | Form 4 sale | 150,000 | $375k | 21.5% | Plan not stated | SEC |
| Aug 20, 2020 | Aug 24, 2020 | Johnson Bankole A. | AZR | Chief Medical Officer | Form 4 sale | 350,000 | $424k | 99.7% | Unusual | SEC |
| Dec 12, 2019 | Dec 13, 2019 | Johnson Bankole A. | AZR | Chief Medical Officer | Form 4 sale | 150,000 | $150k | 17.7% | Plan not stated | SEC |